Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0843
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy ; volume:85 ; number:2 ; day:21 ; month:12 ; year:2019 ; pages:245-250 ; date:2.2020
Cancer chemotherapy and pharmacology ; 85, Heft 2 (21.12.2019), 245-250, 2.2020
- Urheber
-
Baguley, David M.
Prayuenyong, Pattarawadee
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00280-019-04012-z
- URN
-
urn:nbn:de:101:1-2020050914393619916461
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Baguley, David M.
- Prayuenyong, Pattarawadee
- SpringerLink (Online service)
Ähnliche Objekte (12)
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Safety and feasibility of fasting in combination with platinum-based chemotherapy
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma
Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Safety and feasibility of fasting in combination with platinum-based chemotherapy
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma
Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Safety and feasibility of fasting in combination with platinum-based chemotherapy
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma
Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents